Monoamine Oxidase Type B Inhibitors in Human and Animal Parkinsonism

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

1963 • 2,148 citations

Some observations upon a new inhibitor of monoamine oxidase in brain tissue

1968 • 1,589 citations

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1979 • 1,356 citations

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1984 • 1,007 citations

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

1984 • 1,005 citations

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1984 • 575 citations

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons.

1982 • 509 citations

AETIOLOGY OF PARKINSON'S DISEASE

1983 • 463 citations

Catecholamines: Basic and clinical frontiers

1981 • 458 citations

Frontiers in Catecholamine Research

1976 • 451 citations

Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum

1964 • 414 citations

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

1975 • 361 citations

Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.

1973 • 354 citations

DOPAMINE IN THE BASAL GANGLIA: Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)

1973 • 316 citations

Dopamine is a monoamine oxidase B substrate in man

1977 • 313 citations

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE

1977 • 293 citations

Monoamine Oxidase and its Inhibition.

1977 • 263 citations

Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ?cheese effect?

1978 • 245 citations

Neuroregulators and psychiatric disorders

1978 • 233 citations

The deamination of dopamine by human brain monoamine oxidase

1983 • 227 citations

Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase

1970 • 227 citations

EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE

1977 • 145 citations

The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man

1984 • 142 citations

Evidence for a specific monoamine oxidase associated with sympathetic nerves

1971 • 142 citations

(-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson�s Disease

2015 • 135 citations

SELECTIVE ACETYLENIC ‘SUICIDE’ AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND B

1981 • 133 citations

Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors

1972 • 121 citations

δ-Aminolevulinic Acid-Synthesizing Enzymes Need an RNA Moiety for Activity

1984 • 113 citations

TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B

1981 • 103 citations

High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase

1984 • 94 citations

NORADRENALINE METABOLIZING ENZYMES IN NORMAL AND SYMPATHETICALLY DENERVATED VAS DEFERENS

1971 • 89 citations

Overview of present day treatment of Parkinson's disease

1978 • 87 citations

Recent observations on the clinical pharmacology of (-)deprenyl

1978 • 74 citations

RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE INHIBITION OF MONOAMINE OXIDASE TYPES A AND B IN THE RAT VAS DEFERENS

1982 • 58 citations

無傷のミトコンドリアのモノアミンオキシダーゼの多形の,特異的阻害剤と熱安定性とによる特性指摘:8種のほ乳類についての比較

1972 • 52 citations

Monoamine oxidase inhibitors: The state of the art

1981 • 49 citations

The contribution of amphetamine metabolites of (?)-deprenyl to its antiparkinsonian properties

1982 • 47 citations

Characteristics of tyramine induced release of noradrenaline: Mode of action of tyramine and metabolic fate of the transmitter

1980 • 44 citations

Recent advances in the treatment of Parkinson's disease: The role of bromocriptine

1981 • 33 citations

ONTOGENESIS OF ENZYME SYSTEMS DEAMINATING DIFFERENT MONOAMINES

1976 • 32 citations

Social functioning and seizure status of young adults with onset of epilepsy in childhood.

1983 • 28 citations

Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease

1983 • 24 citations

The clinical and biochemical investigation of L-deprenyl in Parkinson's disease with special reference to the ?on-off? effect

1982 • 18 citations

Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamine.

1978 • 15 citations

DEGRADATION OF THE TRANSMITTER AMINES BY SPECIFIC TYPES OF MONOAMINE OXIDASES

1973 • 14 citations

POSTNATAL DEVELOPMENT OF DOPAMINE DEAMINATION IN THE STRIATUM OF THE RAT

1975 • 9 citations

Preface

1983 • 4 citations

Cited By (0)

No citing papers found in database